We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
India will become the largest global hub for COVID-19 antiviral general drug production after the drug controller granted Emergency Use Authorisation (EUA) to several pharmaceutical companies in the country to manufacture...